SCHEMBL13699674

SCHEMBL13699674

COc1ccc2c(N)c(C(N)=O)oc2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 15/20 0.59
ALDH1A1 P00352 11/20 0.59
SMN1; SMN2 Q16637 7/20 0.59
HPGD P15428 7/20 0.59
HSD17B10 Q99714 6/20 0.59
TP53 P04637 1/20 0.59
HTT P42858 1/20 0.59
NPC1 O15118 6/20 0.57
RAB9A P51151 6/20 0.57
MAPT P10636 5/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
LMNA P02545 1/20 0.57
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
TDP1 Q9NUW8 1/20 0.53
POLB P06746 2/20 0.50
CA1 P00915 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20534963 0.89 KDM4E (0.52) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL13624586 0.88 KDM4E (0.59) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL1849885 0.88 KDM4E (0.76) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL28834775 0.87 KDM4E (0.79) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL20535528 0.85 KDM4E (0.47) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL13699690 0.84 KDM4E (0.51) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL20535206 0.80 CA1 (0.48) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL20535803 0.80 KDM4E (0.62) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL13699685 0.80 KDM4E (0.54) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL4251378 0.78 HPGD (0.58) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F KDM4E 4227/4885ALDH1A1 559/4885SMN1; SMN2 2063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.